Bicarbonate buffered peritoneal dialysis fluid upregulates angiopoietin-1 and promotes vessel maturation

Gwendolyn Eich1, Maria Bartosova1, Christian Tischer2

  • 1Center for Pediatric and Adolescent Medicine, University Hospital Heidelberg, Heidelberg, Germany.

Plos One
|December 19, 2017
PubMed

Insights

Bicarbonate buffered peritoneal dialysis fluid promotes vessel maturation by increasing angiopoietin-1, preserving ultrafiltration in dialysis patients. This study reveals the molecular mechanism behind improved ultrafiltration with bicarbonate buffered dialysis fluid.

Area of Science:

  • Nephrology
  • Vascular Biology
  • Biochemistry

Background:

  • Ultrafiltration decline in peritoneal dialysis (PD) is linked to PD fluid-induced peritoneal angiogenesis.
  • Bicarbonate-buffered PD fluid may preserve ultrafiltration better than lactate-buffered fluid, but mechanisms are unclear.

Purpose of the Study:

  • To investigate the molecular mechanisms by which bicarbonate-buffered PD fluid affects endothelial cells and peritoneal angiogenesis.
  • To compare the effects of bicarbonate-buffered PD fluid (BPDF) versus lactate-buffered PD fluid (LPDF) on endothelial cells and peritoneal biopsies.

Main Methods:

  • Assessed angiogenic cytokine profiles, endothelial cell tube formation, and Receptor Tyrosine Kinase translocation in vitro.
  • Analyzed peritoneal biopsies from children on chronic PD using histomorphometry and immunohistochemistry.

Main Results:

  • BPDF significantly increased angiopoietin-1 (ANG1) mRNA and protein in endothelial cells compared to LPDF.
  • BPDF reduced endothelial cell tube formation and promoted Receptor Tyrosine Kinase translocation.
  • Children on BPDF showed larger peritoneal vessels and higher ANG1 expression in CD31+ endothelium compared to LPDF.

Conclusions:

  • Bicarbonate buffered PD fluid promotes vascular maturation through ANG1 upregulation, offering a molecular explanation for preserved ultrafiltration.
  • These findings highlight a potential therapeutic strategy for managing ultrafiltration decline in PD patients.
Abstract